-
Start Preamble
AGENCY:
Centers for Disease Control and Prevention (HHS/CDC), Department of Health and Human Services (HHS).
ACTION:
Correcting amendment.
SUMMARY:
On February 10, 2012, the Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS) published a Direct Final Rule (DFR) that solicited public comment on the establishment of user fees for filovirus testing of all nonhuman primates that die during the HHS/CDC-required 31-day quarantine period for any reason other than trauma. That document incorrectly listed the effective date as March 12, 2012. On February 10, 2012, HHS/CDC also published in the Federal Register a companion Notice of Proposed Rulemaking (NPRM) (77 FR 7109) that proposed identical filovirus testing and user fee requirements. In both the DFR and NPRM, HHS/CDC indicated that if it did not receive any significant adverse comments by April 10, 2012, it would publish a document in the Federal Register withdrawing the NPRM and confirming the effective date of the DFR within 30 days after the end of the comment period.
Because of the error in effective date the DFR took effect prior to the expiration of the comment period. Because of this error and due to receiving significant adverse public comments, HHS/CDC is amending 42 CFR 71.53 by removing paragraph (j) which will have the same effect as the withdrawal of the DFR. HHS/CDC will carefully review the comments received on the notice of proposed rulemaking published on February 10, 2012.
DATES:
This action is effective June 15, 2012.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
For questions concerning this document: Ashley A. Marrone, JD, Centers for Disease Control and Prevention, 1600 Clifton Road NE., Mailstop E-03, Atlanta, Georgia 30333; telephone 404-498-1600. For information concerning program operations: Dr. Robert Mullan, Centers for Disease Control and Prevention, 1600 Clifton Road NE., Mailstop E-03, Atlanta, Georgia 30333; telephone 404-498-1600.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
On February 10, 2012 HHS/CDC published a Direct Final Rule (DFR) (77 FR 6971) amending 42 CFR 71.53 by adding a new paragraph (j) to establish a user fee for filovirus testing of nonhuman primates. HHS/CDC took this action because (1) testing is no longer being offered by the only private, commercial laboratory that previously performed these tests and (2) we believed that these requirements were non-controversial and unlikely to generate significant adverse comment. The DFR incorrectly listed the effective date as March 12, 2012. On February 10, 2012, HHS/CDC also published a companion Notice of Proposed Rulemaking (NPRM) (77 FR 7109) that proposed identical filovirus testing and user fee requirements in the Federal Register. In both the DFR and NPRM, HHS/CDC indicated that if it did not receive any significant adverse comments by April 10, 2012, it would publish a document in the Federal Register withdrawing the notice of proposed rulemaking and confirming the effective date of the direct final rule within 30 days after the end of the comment period. Because of the error in effective date the DFR took effect prior to the expiration of the comment period.
HHS/CDC is now amending 42 CFR 71.53 by removing paragraph (j) which will have the same effect as if HHS/CDC had withdrawn the DFR. HHS/CDC is taking this action because of the error in effective date and due to having received significant adverse public comments. HHS/CDC will carefully review the comments received on the notice of proposed rulemaking published on February 10, 2012.
Start List of SubjectsList of Subjects in 42 CFR Part 71
- Communicable diseases
- Public health
- Quarantine
- Reporting and recordkeeping requirements
- Testing
- User fees
Accordingly, 42 CFR part 71 is corrected by making the following correcting amendment:
Start PartPART 71—FOREIGN QUARANTINE
End Part Start Amendment Part1. The authority citation for part 71 continues to read as follows:
End Amendment Part[Amended]2. Effective June 15, 2012, amend § 71.53 by removing paragraph (j).
End Amendment Part Start SignatureDated: June 6, 2012.
Kathleen Sebelius,
Secretary.
[FR Doc. 2012-14603 Filed 6-14-12; 8:45 am]
BILLING CODE 4163-18-P
Document Information
- Comments Received:
- 0 Comments
- Effective Date:
- 6/15/2012
- Published:
- 06/15/2012
- Department:
- Health and Human Services Department
- Entry Type:
- Rule
- Action:
- Correcting amendment.
- Document Number:
- 2012-14603
- Dates:
- This action is effective June 15, 2012.
- Pages:
- 35878-35878 (1 pages)
- Docket Numbers:
- Docket No. CDC-2012-0003
- RINs:
- 0920-AA47: Establishment of User Fees for Filovirus Testing of Nonhuman Primate Liver Samples
- RIN Links:
- https://www.federalregister.gov/regulations/0920-AA47/establishment-of-user-fees-for-filovirus-testing-of-nonhuman-primate-liver-samples
- Topics:
- Communicable diseases, Public health, Quarantine, Reporting and recordkeeping requirements
- PDF File:
- 2012-14603.pdf
- Supporting Documents:
- » Patient Protection and Affordable Care Act: Benefit and Payment Parameters for 2022; Updates to State Innovation Waiver Implementing Regulations
- » Guidance: Good Guidance Practices; Correction
- » National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table
- » Amendments to the HHS-Operated Risk Adjustment Data Validation Under the Patient Protection and Affordable Care Act's HHS-Operated Risk Adjustment Program
- » Transparency in Coverage
- » UA: Reg Flex Agenda
- » Medicare and Medicaid Programs: CY 2020 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates; Price Transparency Requirements for Hospitals to Make Standard Charges Public
- » Administrative Simplification: Rescinding the Adoption of the Standard Unique Health Plan Identifier and Other Entity Identifier
- » Protecting Statutory Conscience Rights in Health Care; Delegations of Authority
- » Patient Protection and Affordable Care Act: Increasing Consumer Choice through the Sale of Individual Health Insurance Coverage Across State Lines Through Health Care Choice Compacts
- CFR: (1)
- 42 CFR 71.53